Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
about
Identification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gammaOmega-3 fatty acids for the treatment of non-alcoholic fatty liver diseaseLipocalin 13 regulation of glucose and lipid metabolism in obesityExposure to ambient air particulate matter and non-alcoholic fatty liver diseaseLeptin induces an inflammatory phenotype in lean Wistar ratsToll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD).Circulating levels of sirtuin 4, a potential marker of oxidative metabolism, related to coronary artery disease in obese patients suffering from NAFLD, with normal or slightly increased liver enzymes.Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease.Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance.High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism.Lipocalin-13 regulates glucose metabolism by both insulin-dependent and insulin-independent mechanisms.Morphological and metabolic determinants of nonalcoholic fatty liver disease in obese youth: a pilot study.Is serum Interleukin-17 associated with early atherosclerosis in obese patients?The role of PTEN in chronic growth hormone-induced hepatic insulin resistanceComparison of serum ferritin and vitamin d in association with the severity of nonalcoholic Fatty liver disease in korean adults.Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophagesThe heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetesRecent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females.Spleen: A new role for an old player?A model of metabolic syndrome and related diseases with intestinal endotoxemia in rats fed a high fat and high sucrose diet.The influence of metabolic factors for nonalcoholic Fatty liver disease in women.Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver diseaseNon-alcoholic fatty liver disease, diet and gut microbiota.Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injuryAre hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase?Crude triterpenoid saponins from Ilex latifolia (Da Ye Dong Qing) ameliorate lipid accumulation by inhibiting SREBP expression via activation of AMPK in a non-alcoholic fatty liver disease model.Environmentally Relevant Dose of Bisphenol A Does Not Affect Lipid Metabolism and Has No Synergetic or Antagonistic Effects on Genistein's Beneficial Roles on Lipid MetabolismWhat is the role of adiponectin in obesity related non-alcoholic fatty liver disease?Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease.Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?S-Propargyl-cysteine Exerts a Novel Protective Effect on Methionine and Choline Deficient Diet-Induced Fatty Liver via Akt/Nrf2/HO-1 Pathway.Risk factors and mechanisms of non-alcoholic steatohepatitisBiochemical parameters response to weight loss in patients with non-alcoholic steatohepatitisPrevalence and features of fatty liver detected by physical examination in Guangzhou.Thiazolidinedione derivatives in diabetes and cardiovascular disease: an update.Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively?Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease.
P2860
Q24567657-F74CD521-C4D0-420C-A352-D00638C71344Q26825517-798B29B7-C87B-4603-83AF-48C783CB4D94Q26996675-175B75A2-8D1A-4A5F-9E7F-397B1179903FQ26997401-EB816D17-E862-4D1E-9C63-024F24625C75Q28566472-8B212C2B-CD23-4AD5-8E26-B0D6CAF158AEQ30983737-7ED47F6A-A883-44F7-99E1-413329642E36Q33618565-FC0C450D-C837-4591-A37F-96A4928733A0Q33862724-7AFA9EA7-F8AE-40A6-A0EF-F22EF0F3B430Q34168401-7651FB47-EAAD-49F0-B93D-5F4413C8087FQ34200821-50AEF34F-FE14-4C4F-A36D-F8287B59E7A7Q34450673-60E058D2-9A25-42AB-A224-418294EF6FC1Q34528372-9EE2A540-560F-4535-8029-ACB43EB52126Q34623657-35D87B79-8F8A-41E7-98AF-D1FF8D0003AEQ34635257-E3E4F32F-7B6C-4966-A7F6-AFB9CA869717Q34808464-DD7EFE8A-0AED-4D57-9F5B-11050D9C56DFQ34839464-2E6FC138-8B9F-43DB-879F-08F314441786Q35000376-20A9FC64-24F5-46B5-AB0A-DFEFFCFBD02EQ35048289-6CFB1EAA-712C-4B0F-8FE4-3789185189E7Q35127037-916935AC-BDB2-4F57-91F5-0DA14D40E937Q35225973-15B4879A-F431-4F3E-B6BA-DAE7DFF52E63Q35235925-296A5B2D-9D67-4D75-B90D-C1108A98E582Q35515672-96673363-193C-425C-9591-721493595468Q35564120-3B8FD71F-1498-4639-BDF1-E128BB3DA14FQ35638789-171D1DD9-3E07-4FEC-BD02-8ADBEB5725B2Q35728214-5345BE8D-4850-4BCE-8AD7-44C453434D60Q35911420-78474581-E2ED-49F4-91A6-B9803D31BC3DQ35927865-5D7A64DB-C60E-47BE-9D2B-D9DE2C66B6CBQ35982174-94678B1C-1A60-4A52-84D0-A60540FC183BQ36015716-74888F34-CDE4-45A2-AC98-B203B57DD3DFQ36616784-D5E5B9CA-D06A-4886-B7FC-C57157A2DD1AQ36800964-314C869C-B88F-4693-8CFF-3AD383CE59F1Q36872035-B5A4B043-6F07-4956-9C8A-E19C0F39A467Q36932044-20E935A6-DEC8-48DB-9F31-C79E8125AB63Q36969802-1A16264A-F5AB-49CB-B58C-92F4DFA28237Q37009739-FDB5FA2D-A589-4285-9C96-A3FA424AC936Q37025294-DD88B811-B17D-4711-827A-ADBE79FF35EDQ37118863-099E1628-63DC-46E0-9DCB-9CCB0CDDB438Q37142138-EE95B0A0-2234-4AF8-8B4A-00138678D42AQ37145912-9B7438FC-5852-4176-9FBA-0ED866A86AEDQ37266370-52E2A77E-15E0-41AA-8924-8A70092A5855
P2860
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
@ast
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
@en
type
label
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
@ast
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
@en
prefLabel
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
@ast
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
@en
P2093
P2860
P1476
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
@en
P2093
Adriano Arena
Gennaro Saldalamacchia
Giovanni Tarantino
Paolo Conca
P2860
P304
P356
10.1111/J.1440-1746.2007.04824.X
P577
2007-03-01T00:00:00Z